TotalMarketCap

Pharming Group

PHARNasdaq NetherlandsHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$884.934 M

$12.53 -1.88%

Close of 6 Nov 2026

As of 6 Nov 2026, Pharming Group (PHAR) has a market capitalization of $884.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

701,680,440

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #147SavaraSVRA$896.8M
  2. #148Jade BiosciencesJBIO$896.1M
  3. #149Pharming GroupPHAR$884.9M
  4. #150Oric PharmaceuticalsORIC$883.1M
  5. #151Latigo BiotherapeuticsLTGO$865.9M

What if Pharming Group were worth as much as…

Open the what-if tool →

Gold $28.2T

$399,812.84

Per share 31,908× higher

Bitcoin $1.53T

$21,633.18

Per share 1,727× higher

Apple $5.02T

$71,019.70

Per share 5,668× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Pharming Group are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.